Follow
MAXCYTE INC
London AIM (United Kingdom)
Maxcyte provides patented, high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology.
Sector:
HEALTH CARE
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
MXCT
US57777K1060
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCT
Status
Active
SEDOL
BYVJZ42
Amount of instruments
Par value
Market cap
Currency
GBP
Segment
ASQ1
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
70 pence
22.6M GBP
29 Mar 2016
Direct listing of MAXCYTE INC on London AIM
Type
Price
Pre-money valuation
Time
Files
New issue
1.70 pence
87.27M GBP
05 Feb 2019
Share issue in MAXCYTE INC
Type
Ticker
ISIN
Market
SHARE
MXCL
USU575803072
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCL
Status
Active
SEDOL
BK962S0
Amount of instruments
9 900 089
Par value
Market cap
Currency
GBP
Segment
ASX1
Terms
Type
Price
Pre-money valuation
Time
Files
Targeted issue
131 pence
100.33M GBP
21 May 2020
Share issue in MAXCYTE INC
Type
Ticker
ISIN
Market
SHARE
MXCT
US57777K1060
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCT
Status
Active
SEDOL
BYVJZ42
Amount of instruments
Par value
Market cap
Currency
GBP
Segment
ASQ1
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
70 pence
22.6M GBP
29 Mar 2016
Direct listing of MAXCYTE INC on London AIM
Type
Price
Pre-money valuation
Time
Files
New issue
1.70 pence
87.27M GBP
05 Feb 2019
Share issue in MAXCYTE INC
Type
Ticker
ISIN
Market
SHARE
MXCL
USU575803072
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCL
Status
Active
SEDOL
BK962S0
Amount of instruments
9 900 089
Par value
Market cap
Currency
GBP
Segment
ASX1
Terms
Type
Price
Pre-money valuation
Time
Files
Targeted issue
131 pence
100.33M GBP
21 May 2020
Share issue in MAXCYTE INC
Type
Ticker
ISIN
Market
SHARE
MXCR
USU575801092
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCR
Status
Archived
SEDOL
Amount of instruments
Par value
Market cap
Currency
GBP
Segment
ASX1
Terms
Type
Ticker
ISIN
Market
SHARE
MXCS
USU575801175
London AIM
United Kingdom (GB)
Details of share in MAXCYTE INC with ticker MXCS
Status
Archived
SEDOL
BFN3B18
Amount of instruments
Par value
Market cap
Currency
GBP
Segment
ASX1
Terms
People
Doug Doerfler
CEO
Stark Thompson
Chairman of the board
Will Brooke
Board member
Richard Douglas
Board member
Stan Erck
Board member
John Johnston
Board member
Art Mandell
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE
Zip code
19808
City/district
WILMINGTON
Country
United States (US)
Registration number
2927945
LEI code
54930053YHXULRFCU991
First trade date
29 Mar 2016
Registration date
31 Jul 1998
Short name
MAXCYTE

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date